Search News
| 238.05 BATS BZX Real-Time Price As of 11:44am ET |  -9.93 / -4.00%Today’s Change | 123.11 Today|||52-Week Range 255.38 | +73.85% Year-to-Date |
| Previous close | 247.98 |
| Today’s open | 245.11 |
| Day’s range | 236.94 - 245.11 |
| Volume | 6,118 |
| Average volume (3 months) | 336,962 |
| Market cap | $5.2B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +86.25% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +29.48% |
| P/E ratio | 49.1 |
| Price/Sales | 22.79 |
| Price/Book | 13.09 |
| Today’s change | Today’s % change | |
|---|---|---|
| GWPHGW Pharmaceuticals P... | -2.05 | -1.51% |
| PBHPrestige Consumer He... | -0.28 | -0.72% |
| MDCOMedicines Co | -0.59 | -1.48% |
| ICPTIntercept Pharmaceut... | +0.54 | +0.52% |
| Next reporting date | October 31, 2018 |
| EPS forecast (this quarter) | $1.08 |
| Annual revenue (last year) | $141.1M |
| Annual profit (last year) | $12.6M |
| Net profit margin | 8.90% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director John L. Higgins |
President & Chief Operating Officer Matthew W. Foehr |
Corporate headquarters San Diego, California |
